pharmexec.com /1 week ago

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Pimjetmi]]>

Read source
pharmexec.com /1 month ago

<![CDATA[Pharmaceutical Executive Daily: FDA Grants Accelerated Approval to Jemperli]]>

Read source
pharmexec.com /1 week ago

<![CDATA[FDA Approves Pimjetmi for Patients With Tenosynovial Giant Cell Tumor]]>

Read source
pharmexec.com /1 month ago

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Onswik]]>

Read source
pharmexec.com /1 month ago

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Hibsago]]>

Read source
pharmexec.com /1 month ago

<![CDATA[FDA Approves Onswik for Adults with Type 2 Diabetes ]]>

Read source
pharmexec.com /2 weeks ago

<![CDATA[FDA Grants Accelerated Approval to Rybrevant Faspro in Head and Neck Cancer]]>

Read source
pharmexec.com /1 week ago

<![CDATA[FDA Approves asundexian for Secondary Stroke Risk Reduction ]]>

Read source
pharmexec.com /4 weeks ago

<![CDATA[FDA Approves Subcutaneous Induction for Skyrizi in Crohn's Disease]]>

Read source
pharmexec.com /1 month ago

<![CDATA[FDA Grants Accelerated Approval to Jemperli for MSI-H/dMMR Locally Advanced Rectal Cancer]]>

Read source
pharmexec.com /6 days ago

<![CDATA[FDA Approves Klygefa for gMG, Gazyva for Primary Membranous Nephropathy, Igalmi for Agitation Associated wit...

Read source
pharmexec.com /1 month ago

<![CDATA[FDA Approves Hibsago (Bepirovirsen) for Chronic Hepatitis B]]>

Read source
pharmexec.com /2 weeks ago

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Voceryq]]>

Read source
pharmexec.com /2 weeks ago

<![CDATA[Pharmaceutical Executive Daily: FDA Grants Accelerated Approval to Rybrevant Faspro]]>

Read source
pharmexec.com /2 weeks ago

<![CDATA[FDA Grants Accelerated Approval to INOVIO’s Voceryq for RRP, Reducing Surgical Burden]]>

Read source
pharmexec.com /1 month ago

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Tecentriq]]>

Read source
pharmexec.com /1 month ago

<![CDATA[FDA Approves Tukysa Plus Trastuzumab and Pertuzumab as First-Line Maintenance Treatment for HER2-Positive Me...

Read source
pharmexec.com /3 weeks ago

<![CDATA[FDA Approves Ilumya for Adults With Active Psoriatic Arthritis]]>

Read source
pharmexec.com /1 month ago

<![CDATA[FDA Approves Welireg Plus Lenvima for Previously Treated Adult Patients With ccRCC]]>

Read source
pharmexec.com /1 month ago

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Expanded Indication for Camzyos]]>

Read source
pharmexec.com /1 month ago

<![CDATA[FDA Grants Ultomiris Accelerated Approval in the U.S. for Adults with Primary Immunoglobulin A Nephropathy ]...

Read source
pharmexec.com /1 month ago

<![CDATA[FDA Approves Enspryng (Satralizumab) for Thyroid Eye Disease]]>

Read source
pharmexec.com /1 month ago

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Welireg Plus Lenvima]]>

Read source
biopharmadive.com /4 days ago

Roche breast cancer pill cleared by FDA

Wilserdly’s U.S. approval is seen by analysts as a “key first step” in an important launch for Roche, which has claimed the drug could become its top-selling product.

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Related searches